CME Group Inc (CME) Shares Sold by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. lowered its stake in shares of CME Group Inc (NASDAQ:CME) by 9.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 607,290 shares of the financial services provider’s stock after selling 62,203 shares during the period. Asset Management One Co. Ltd. owned approximately 0.18% of CME Group worth $82,411,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the stock. Fiduciary Trust Co. purchased a new position in CME Group in the 2nd quarter valued at approximately $105,000. Quadrant Capital Group LLC boosted its position in CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after buying an additional 113 shares during the period. San Francisco Sentry Investment Group CA purchased a new position in CME Group in the 2nd quarter valued at approximately $129,000. People s United Financial Inc. boosted its position in CME Group by 11.5% in the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after buying an additional 110 shares during the period. Finally, Parallel Advisors LLC boosted its position in CME Group by 12.2% in the 2nd quarter. Parallel Advisors LLC now owns 1,216 shares of the financial services provider’s stock valued at $149,000 after buying an additional 132 shares during the period. 83.17% of the stock is owned by hedge funds and other institutional investors.
In related news, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total transaction of $342,075.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Dennis Suskind sold 750 shares of CME Group stock in a transaction on Monday, September 11th. The stock was sold at an average price of $129.34, for a total transaction of $97,005.00. Following the sale, the director now owns 5,059 shares in the company, valued at $654,331.06. The disclosure for this sale can be found here. Insiders have sold a total of 34,921 shares of company stock worth $5,016,248 over the last quarter. 0.57% of the stock is owned by company insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. During the same period last year, the business earned $1.05 EPS. CME Group’s revenue for the quarter was up 5.8% compared to the same quarter last year. sell-side analysts anticipate that CME Group Inc will post 4.78 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 annualized dividend and a yield of 1.74%. CME Group’s dividend payout ratio is currently 59.86%.
Several equities analysts have commented on CME shares. Barclays started coverage on shares of CME Group in a research report on Friday, September 8th. They issued an “overweight” rating and a $139.00 price target for the company. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. UBS reissued a “buy” rating and issued a $135.00 price target (up previously from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Citigroup raised their price objective on shares of CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, October 19th. Finally, Wells Fargo & Company raised their price objective on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and a consensus price target of $141.75.
COPYRIGHT VIOLATION WARNING: This story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/12/06/cme-group-inc-cme-shares-sold-by-asset-management-one-co-ltd.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Stock Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related stocks with our FREE daily email newsletter.